Novanta Prices $300M Private Placement at 12.86% Discount, Diluting Shares by 6%
NOVT sits 63% above its 52-week low of $98.27 on elevated volume (2.1× avg).
Summary
Novanta Inc. announced a $300 million private placement of common shares at a 12.86% discount to the current market price, leading to 6.01% dilution for existing shareholders, likely to fund a major acquisition.
Key Events · Financing and Capital Events · NOVT
-
Private Placement Priced
Novanta Inc. entered into a Securities Purchase Agreement for a private placement of 2,142,857 common shares at $140.00 per share, raising approximately $300 million in gross proceeds.
-
Significant Discount to Market Price
The offering price of $140.00 per share is a 12.86% discount compared to the current market price of $160.65.
-
Share Dilution
The issuance of new shares will result in a 6.01% dilution for existing shareholders, based on 35,613,303 shares outstanding prior to the placement.
-
Registration Rights Agreement
The company also entered into a Registration Rights Agreement, committing to register the resale of the common shares sold in the private placement.
Analysis · NOVT · Manufacturing
Novanta Inc. has finalized a private placement to raise approximately $300 million by selling 2,142,857 common shares at $140.00 per share. This pricing represents a significant 12.86% discount compared to the current stock price of $160.65. The transaction will result in a 6.01% dilution for existing shareholders. This substantial capital raise, representing 5.24% of the company's market capitalization, is likely intended to fund the $1.45 billion acquisition of Riverpoint Medical, which was also announced today.
At the time of this filing, NOVT was trading at $160.65 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $98.27 to $171.85. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.